Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
06 April 2006Website:
http://www.metagenomi.coNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:13:54 GMTDividend
Analysts recommendations
Institutional Ownership
MGX Latest News
North Bay Resources Inc. (OTC:NBRI) has entered into a 50-50 joint venture earn-in agreement with MGX Minerals for the Fran gold project located in British Columbia. North Bay can earn up to an initial 30% interest in the project by completing a resource estimate and producing 2,500 ounces of gold within a year.
Metagenomi just raised $94 million in its initial public offering. It now has enough money to last it for a few years.
Genetic medicines company Metagenomi Technologies MGX.O said on Thursday it is aiming for a valuation of $563 million in its U.S. initial public offering (IPO), a number that is at the low end of its initial target range.
What type of business is Metagenomi Common Stock?
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.
What sector is Metagenomi Common Stock in?
Metagenomi Common Stock is in the Healthcare sector
What industry is Metagenomi Common Stock in?
Metagenomi Common Stock is in the Biotechnology industry
What country is Metagenomi Common Stock from?
Metagenomi Common Stock is headquartered in United States
When did Metagenomi Common Stock go public?
Metagenomi Common Stock initial public offering (IPO) was on 06 April 2006
What is Metagenomi Common Stock website?
https://www.metagenomi.co
Is Metagenomi Common Stock in the S&P 500?
No, Metagenomi Common Stock is not included in the S&P 500 index
Is Metagenomi Common Stock in the NASDAQ 100?
No, Metagenomi Common Stock is not included in the NASDAQ 100 index
Is Metagenomi Common Stock in the Dow Jones?
No, Metagenomi Common Stock is not included in the Dow Jones index
When does Metagenomi Common Stock report earnings?
The next expected earnings date for Metagenomi Common Stock is 30 August 2024